Health

Lawyers and regulators are concerned about the lack of regulations for the use of robotic technology in surgeries.

FDA warns consumers that the agency has not evaluated most CBD products and cannot say they are safe.

Unlike new drugs and devices, combination products may fall through the regulatory cracks.

Recent outbreaks of vaccine-preventable diseases fuel debate about vaccine policy.

Brazil has recently made efforts to streamline the introduction and distribution of drugs.

Court sides with insurance companies in cost-sharing subsidies class action despite their use of “silver loading.”

Policymakers around the world are determining how to apply existing regulations to 3D organ printing.

Scholars are divided on how to regulate heritable genome editing.

To fight opioid misuse, the U.S. government proposes expanding access to medical records on substance use.

Scholar argues that FDA can, and should, regulate marijuana edibles.

Experts suggest changing Medicare’s payment structure to encourage physicians to pursue primary care specialties.

As the United States struggles with opioid addiction, litigation rages over medically supervised consumption facilities.